Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12Neoplasms 7Fatigue 6Prostatic Neoplasms 5Lung Neoplasms 5Motor Activity 4Lymphedema 4Hematologic Neoplasms 4Pain 3Trismus 2Peripheral Nervous System Diseases 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Glioma 2Esophageal Neoplasms 2Cachexia 2Breast Neoplasms, Male 2Urologic Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Transcranial Magnetic Stimulation, Repetitive 1Thrombosis 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sleep Initiation and Maintenance Disorders 1Shoulder Pain 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Testosterone 2Laser Therapy 2Coconut Oil 2Water 1Vitamin E 1Transcranial Direct Current Stimulation 1Testosterone Propionate 1Sodium Chloride 1Replens 1Physical Therapy Modalities 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dyspareunia × Physical Therapy Modalities × Clear all
NCT03935698 2022-01-27

Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study

Université de Sherbrooke

Phase NA Completed
31 enrolled

Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡